Retractable Technologies, Inc.

RVP Healthcare Medical Instruments & Supplies

Retractable Technologies, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $38.3 million, up 15.8% from fiscal 2024. In the quarter to June 2026, revenue fell 31.1%, EPS was flat, free cash flow grew 56.7% and total debt fell 32.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

0.58 0.01 −1.69%
Market cap
$17.6M
P/E
0.0×
Fwd P/E
11.1×
Dividend yield
—
F-score
5/9
Altman Z
0.57
Beneish M
−15.44
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.64 0.53 0.60 0.66
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(12.44) (14.44) (38.64) (19.99)
P/B ratio
0.30 0.28 0.31 0.33
EV/Sales
(0.52) (0.41) (0.34) (0.21)
EV/EBITDA
1.18 1.01 0.97 0.59
EV/FCF
3.45 2.03 1.71 0.93
Current Ratio
4.93 5.74 6.57 6.66
Net Debt/EBITDA
12.05 8.17 6.48 18.44
Debt/Equity
0.01 0.01 0.01 0.01
Earnings Yield
(16.67%) (31.82%) (54.55%) (25.00%)
Free Cash Flow Yield
(23.70%) (37.51%) (32.97%) (33.32%)
Free Cash Flow per Share
(0.06) (0.05) (0.02) (0.04)
Book value per Share
2.43 2.34 2.48 2.56
Free Cash Flow
(1.76) (1.37) (0.62) (1.35)
EV/EBIT
0.78 0.66 0.62 0.38
Other line items

Show all line items

Columns are period end dates